Senior Manager, R&D Quality Data & Decision Excellence at Bristol-Myers Squibb

Hyderabad, Telangana, India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • Expertise in advanced analytics, Gen AI/Machine Learning solutions, and emerging technologies
  • Proficiency in analytical tools, software, statistical analysis techniques, and data visualization
  • Knowledge of R&D Quality processes, GxP compliance, quality metrics, and risks
  • Ability to act as subject matter expert (SME) on analytics, AI, and machine learning, including training teams
  • Understanding of BMS processes, SOPs, and regulatory standards
  • Experience collaborating with stakeholders, BI&T, Global Quality teams, and RDQ pillars
  • Capability to lead/participate in internal work streams, projects, and improvement initiatives as QA representative

Responsibilities

  • Work closely with stakeholders and RDQ pillars to understand innovation needs and propose solutions using advanced analytics and Gen AI/ML for process optimization and data-driven decisions
  • Proactively identify innovation areas, create and execute strategies to deliver capabilities
  • Assess external landscape, stay informed on industry practices, and propose fit-for-purpose solutions to optimize R&D Quality processes
  • Champion digital first mindset and culture of innovation; attend/present at industry conferences to represent BMS and advance strategies
  • Collaborate to develop/implement strategies enhancing RDQ process maturity, including optimization, training, and continuous improvement
  • Promote data as an asset; deliver metrics/KPIs, visualize insights clearly, and oversee dashboard development/maintenance with RDQ pillars and BI&T for real-time visibility
  • Analyze R&D Quality data, identify patterns/trends, and apply statistical techniques for insights and improvements
  • Provide recommendations to enhance metrics measuring/predicting GxP compliance, quality, and risks
  • Promote culture of psychological safety, inclusion, and diversity; train teams on solutions to increase adoption
  • Develop/provide regular reports/updates to RDQ leadership on strengths and opportunities
  • Provide data/input for enterprise continuous improvement; collaborate with BI&T and Global Quality on data curation/analysis
  • Function as QA SME/representative in relevant topics, work streams, projects, and initiatives
  • Ensure compliance with BMS processes, SOPs, regulatory standards; responsible for quality of deliverables
  • Set, monitor, and analyze globally aligned metrics across RDQ pillars (Clinical Quality, Laboratory Sciences Quality, Pharmacovigilance Quality)

Skills

Advanced Analytics
Generative AI
Machine Learning
Process Optimization
Data-Driven Decision Making
Innovation Strategy
R&D Quality

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI